Literature DB >> 6667401

Estimating increases in skin cancer morbidity due to increases in ultraviolet radiation exposure.

T R Fears, J Scotto.   

Abstract

It is generally accepted that if ozone levels in the stratosphere are depleted, greater amounts of shortwave ultraviolet radiation (UVB) will reach the earth's surface, resulting in increased morbidity of nonmelanoma skin cancer. The incidence and UVB data are now available from a new epidemiologic study of skin cancer conducted at eight locations of the United States. We found that either a simple power function or a simple exponential function could be used to describe these new data. According to estimates based on the power model, should the amount of exposure to UVB increase by 30%, then the incidence of skin cancer will increase by 60% in males and 45% in females. Estimates based on the exponential model vary by location, (53-96)% in males and (39-68)% in females. These estimates are somewhat lower than those based only on earlier data. We emphasize that skin cancer rates also depend on variables other than UVB which may be location specific.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6667401     DOI: 10.3109/07357908309042414

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  13 in total

Review 1.  Bilateral hand squamous-cells carcinoma in patient affected with non-Hodgkin lymphoma. Case report and literature review.

Authors:  P Fino; A M Spagnoli; M Ruggieri; M Marcasciano; N Scuderi
Journal:  G Chir       Date:  2015 Jul-Aug

2.  UVB upregulates the bax promoter in immortalized human keratinocytes via ROS induction of Id3.

Authors:  Valerie Anne Trabosh; Ahmad Daher; Kyle A Divito; Karishma Amin; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal
Journal:  Exp Dermatol       Date:  2008-10-23       Impact factor: 3.960

3.  Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity.

Authors:  Kyung Mi Lee; Ki Won Lee; Sung Keun Jung; Eun Jung Lee; Yong-Seok Heo; Ann M Bode; Ronald A Lubet; Hyong Joo Lee; Zigang Dong
Journal:  Biochem Pharmacol       Date:  2010-07-01       Impact factor: 5.858

4.  Antitumor effects of recombinant human adenovirus-p53 against human cutaneous squamous cell carcinoma in mice.

Authors:  Yuanchao Li; Wei He; Rupeng Wang; Libin Yang; Chunli Zhou; Bin Zhang
Journal:  Exp Ther Med       Date:  2016-11-14       Impact factor: 2.447

Review 5.  Sun exposure and non-melanocytic skin cancer.

Authors:  A Kricker; B K Armstrong; D R English
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

6.  Changing Trends of Skin Cancer: A Tertiary Care Hospital Study in Malwa Region of Punjab.

Authors:  Sonal Tina Lal; Raja Paramjeet Singh Banipal; Deepak John Bhatti; Hanuman Prasad Yadav
Journal:  J Clin Diagn Res       Date:  2016-06-01

7.  Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes.

Authors:  Jasbani H S Dayal; Clare L Cole; Celine Pourreyron; Stephen A Watt; Yok Zuan Lim; Julio C Salas-Alanis; Dedee F Murrell; John A McGrath; Bruno Stieger; Colin Jahoda; Irene M Leigh; Andrew P South
Journal:  J Cell Sci       Date:  2013-12-19       Impact factor: 5.285

8.  Nonmelanoma skin cancer in India: current scenario.

Authors:  Saumya Panda
Journal:  Indian J Dermatol       Date:  2010-10       Impact factor: 1.494

9.  Secreted frizzled-related protein promotors are hypermethylated in cutaneous squamous carcinoma compared with normal epidermis.

Authors:  Junqin Liang; Xiaojing Kang; Yilinuer Halifu; Xuewen Zeng; Tianbo Jin; Mingxia Zhang; Dong Luo; Yuan Ding; Yunmin Zhou; Buwajier Yakeya; Dilinuer Abudu; Xiongming Pu
Journal:  BMC Cancer       Date:  2015-09-22       Impact factor: 4.430

10.  UV-B exposure impairs resistance to infection by Trichinella spiralis.

Authors:  W Goettsch; J Garssen; A Deijns; F R de Gruijl; H van Loveren
Journal:  Environ Health Perspect       Date:  1994-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.